| Ranbaxy Laboratories Limited - SWOT Analysis | | | | operates in India, Europe, North America and Asia |
| company profile is the essential source for top-level | | | | Pacific. It is headquartered in Gurgaon, India and |
| company data and information. Ranbaxy Laboratories | | | | employed 8,536 people as of December 2008. The |
| Limited - SWOT Analysis examines the company's | | | | company recorded revenues of INR76,919.8 million |
| key business structure and operations, history and | | | | ($1,776.1 million*) during the financial year (FY) ended |
| products, and provides summary analysis of its key | | | | December 2008, an increase of 11.2% over FY2007. |
| revenue lines and strategy. | | | | The operating loss of the company was INR2,626.3 |
| Ranbaxy Laboratories (Ranbaxy), the largest generic | | | | million ($60.6 million*) during FY2008, as compared |
| pharmaceutical company in India, is engaged in the | | | | with an operating profit of INR10,509.4 million ($242.7 |
| manufacture and trade of formulations, active | | | | million*) in FY2007. The net loss was INR9,512.1 million |
| pharmaceuticals ingredients (API) and intermediates, | | | | ($219.6 million*) in FY2008, as compared with a net |
| generics, drug discovery and consumer health care | | | | profit of INR7,745.9 million ($178.9 million*) in FY2007. |
| products. It also focuses on research and | | | | * Calculated using the constant currency conversion |
| development activities primarily in India. The company | | | | rate of INR1 = $0. |